BioCentury
ARTICLE | Company News

Speedel, Novartis deal

August 11, 2008 7:00 AM UTC

Speedel’s board recommended that shareholders accept last month’s tender offer by Novartis to buy the remainder of the company for CHF130 per share. Novartis announced the offer on July 10, after it a...